Drugs / LT4
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT01295333 | May 2011 → Nov 2014 | Graves disease | Assistance Publique Hopitaux De Marseille | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT05247476 Comparator | Oct 2021 → Mar 2022 | postsurgical hypothyroidism, thyroid gland papillary carcinoma | Zhongshan Hospital Xiamen University | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | L-T4 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05247476 ↗ |